Moreover, data from cohort 3 showed that high CCDC8 expression is significantly associated with poorer treatment response (SD/PD) (Figure 7C) but is not significantly related to tumor immune phenotypes, immune cell infiltration classifications, IC levels, or TC levels (Figure 7D-G). This evidence concerns the gene CCDC8 and neoplasm.